Can Knowledge About Heterogeneity in Treatment Effects Help Us Choose Wisely?

被引：13

作者：

Davidoff, Frank ^{[1
]}

机构：

[1] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2017年 / 166卷 / 02期

关键词：

D O I：

10.7326/M16-1721

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：141 / +

页数：3

共 11 条

[1] Assessing the Gold Standard - Lessons from the History of RCTs [J].

Bothwell, Laura E. ;

Greene, Jeremy A. ;

Podolsky, Scott H. ;

Jones, David S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (22) :2175-2181

[2] The Science of Choosing Wisely - Overcoming the Therapeutic Illusion [J].

Casarett, David .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (13) :1203-1205

[3]

Dahabreh IJ, 2016, INT J EPIDE IN PRESS

[4] Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature [J].

Gagnier, Joel J. ;

Moher, David ;

Boon, Heather ;

Beyene, Joseph ;

Bombardier, Claire .

BMC MEDICAL RESEARCH METHODOLOGY, 2012, 12

[5] Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis [J].

Hayward R.A. ;

Kent D.M. ;

Vijan S. ;

Hofer T.P. .

BMC Medical Research Methodology, 6 (1)

[6] Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal [J].

Kent, David M. ;

Rothwell, Peter M. ;

Ioannidis, John Pa ;

Altman, Doug G. ;

Hayward, Rodney A. .

TRIALS, 2010, 11

[7]

Kent DM, 2016, INT J EPIDEMIOL

[8]

Rothwell PM., 2007, Treating individuals: from randomised trials to personalised medicine

[9]

Schmid CH, 1998, STAT MED, V17, P1923, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO

[10]

2-6

← 1 2 →